Dianomi Therapeutics, Inc. — Form D
Dianomi Therapeutics, Inc. of MADISON, WI, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-11. The offering totals $2.0M, of which $185K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-04-11
- Form: D
- Accession: 0001737087-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $185K
- Remaining: $1.8M
- Minimum investment: $100K
- Investors: 5
- Date of first sale: 2018-03-30
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-309836
Issuer
- Name: Dianomi Therapeutics, Inc.
- CIK: 0001737087
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 504 SOUTH ROSA ROAD, MADISON, WI, 53719
- Phone: 303-880-9590
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| William Murphy | Director | Chicago, IL |
| William Murphy | Executive Officer | Chicago, IL |
| Carter Cliff | Director | Cambridge, MA |
| Carter Cliff | Executive Officer | Cambridge, MA |
| Kurtis Knapp | Director | Madison, WI |
| Kurtis Knapp | Executive Officer | Madison, WI |
| Barry Kurokawa | Director | Parker, CO |
| Barry Kurokawa | Executive Officer | Parker, CO |
Other filings by this issuer (1)
More